Cell Signaling Technology

CNPase Antibody

#2986 · $317

100
Citing papers
14.5k
Combined citations
Supplier page Find this product

Research areas

interferon and immune responses10Autophagy in Disease and Therapy8Immune Response and Inflammation7Immune Cell Function and Interaction7Endoplasmic Reticulum Stress and Disease6Cell Adhesion Molecules Research5Hepatitis C virus research5Neuroscience and Neuropharmacology Research5

Papers citing this product

1
Brown adipose tissue regulates glucose homeostasis and insulin sensitivity
Journal of Clinical Investigation·2012·1.2k cit.·DOI
2
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
American Journal Of Pathology·2004·536 cit.·DOI
3
Paracrine and Autocrine Regulation of Epidermal Growth Factor-Like Factors in Cumulus Oocyte Complexes and Granulosa Cells: Key Roles for Prostaglandin Synthase 2 and Progesterone Receptor
Molecular Endocrinology·2006·422 cit.·DOI
4
Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ϵ
Journal of Biological Chemistry·2009·382 cit.·DOI
5
Apoptosis Induced by the Toll-Like Receptor Adaptor TRIF Is Dependent on Its Receptor Interacting Protein Homotypic Interaction Motif
The Journal of Immunology·2005·365 cit.·DOI
6
Activation of AMP-activated Protein Kinase Inhibits Protein Synthesis Associated with Hypertrophy in the Cardiac Myocyte
Journal of Biological Chemistry·2004·330 cit.·DOI
7
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
Nature Communications·2018·275 cit.·DOI
8
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer·2021·269 cit.·DOI
9
1,25(OH)2Vitamin D3 Stimulates Myogenic Differentiation by Inhibiting Cell Proliferation and Modulating the Expression of Promyogenic Growth Factors and Myostatin in C2C12 Skeletal Muscle Cells
Endocrinology·2011·258 cit.·DOI
10
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
British Journal of Cancer·2006·257 cit.·DOI

Similar products

ProductVendorPricePapers
CNPase (D83E10) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$161100
CNPase (D83E10) Mouse Chimeric Monoclonal AntibodyMouse chimericCell Signaling Technology$16118
CNPase (D83E10) Feline Chimeric Monoclonal AntibodyFeline chimericCell Signaling Technology$16111
CNPase (D83E10) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology$86511
CNPase (D83E10) Horse Chimeric Monoclonal AntibodyHorse chimericCell Signaling Technology$1614
CNPase (F6Y2X) Mouse Monoclonal AntibodyMouseCell Signaling Technology$148—